Abstract |
Urine could be a convenient source of biomarkers for different diseases and clinical applications, mostly for cancer diagnosis, prognosis, treatment monitoring, and prenatal diagnosis. The ultra-noninvasive sampling and the possibility to analyze large volume are the main undisputed advantages of urine-based protocols. Recent and comprehensive studies showed that urinary cell-free DNA (ucfDNA) is informative to identify the genomic signature of patients, resulting in a huge tool to track the tumor evolution and for personalized medicine in urological and non- urological cancer.In this chapter, we reported the main published evidences on ucfDNA, with the aim at discussing its promising and translatable role in clinical practices.
|
Authors | Samanta Salvi, Valentina Casadio |
Journal | Methods in molecular biology (Clifton, N.J.)
(Methods Mol Biol)
Vol. 1909
Pg. 201-209
( 2019)
ISSN: 1940-6029 [Electronic] United States |
PMID | 30580433
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Animals
- Cell-Free Nucleic Acids
(genetics, isolation & purification, urine)
- DNA Copy Number Variations
- Female
- Humans
- Mutation
- Neoplasms
(diagnosis, genetics, urine)
- Polymerase Chain Reaction
(methods)
- Pregnancy
- Prenatal Diagnosis
(methods)
- Prognosis
- Urine Specimen Collection
(methods)
|